Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 34% ± 15% | |
peripheral blood | 14 studies | 29% ± 10% | |
brain | 12 studies | 26% ± 12% | |
intestine | 11 studies | 30% ± 15% | |
eye | 10 studies | 45% ± 23% | |
kidney | 9 studies | 34% ± 8% | |
liver | 7 studies | 26% ± 14% | |
pancreas | 5 studies | 45% ± 22% | |
uterus | 5 studies | 34% ± 18% | |
lymph node | 5 studies | 31% ± 16% | |
placenta | 4 studies | 52% ± 22% | |
prostate | 4 studies | 30% ± 12% | |
breast | 4 studies | 31% ± 1% | |
bone marrow | 3 studies | 24% ± 5% | |
adrenal gland | 3 studies | 28% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6526.14 | 459 / 459 | 100% | 271.33 | 1118 / 1118 |
intestine | 100% | 8250.22 | 966 / 966 | 100% | 376.09 | 527 / 527 |
liver | 100% | 8134.52 | 226 / 226 | 100% | 241.59 | 406 / 406 |
stomach | 100% | 8934.71 | 359 / 359 | 100% | 333.90 | 286 / 286 |
skin | 100% | 12102.77 | 1807 / 1809 | 100% | 319.13 | 472 / 472 |
kidney | 100% | 11859.44 | 89 / 89 | 100% | 306.84 | 900 / 901 |
esophagus | 100% | 8493.42 | 1443 / 1445 | 100% | 246.98 | 183 / 183 |
bladder | 100% | 6715.14 | 21 / 21 | 100% | 295.39 | 503 / 504 |
ovary | 99% | 4793.62 | 179 / 180 | 100% | 176.31 | 430 / 430 |
prostate | 100% | 6523.84 | 244 / 245 | 100% | 212.78 | 501 / 502 |
lung | 99% | 6843.45 | 573 / 578 | 100% | 213.69 | 1155 / 1155 |
thymus | 99% | 5628.67 | 649 / 653 | 99% | 157.25 | 600 / 605 |
brain | 98% | 9906.26 | 2599 / 2642 | 100% | 206.71 | 705 / 705 |
adrenal gland | 100% | 10142.98 | 258 / 258 | 98% | 233.30 | 226 / 230 |
uterus | 97% | 4117.26 | 165 / 170 | 100% | 251.23 | 458 / 459 |
pancreas | 97% | 4285.26 | 317 / 328 | 100% | 260.74 | 178 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 284.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 282.62 | 29 / 29 |
muscle | 100% | 36275.88 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4939.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 236.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 87.70 | 1 / 1 |
adipose | 100% | 7083.01 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 6527.86 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 17642.31 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 54% | 7509.51 | 504 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0006090 | Biological process | pyruvate metabolic process |
GO_0007612 | Biological process | learning |
GO_1905091 | Biological process | positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization |
GO_0007270 | Biological process | neuron-neuron synaptic transmission |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_1903146 | Biological process | regulation of autophagy of mitochondrion |
GO_0110099 | Biological process | negative regulation of calcium import into the mitochondrion |
GO_0006820 | Biological process | monoatomic anion transport |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0001662 | Biological process | behavioral fear response |
GO_0006915 | Biological process | apoptotic process |
GO_0036444 | Biological process | calcium import into the mitochondrion |
GO_0005886 | Cellular component | plasma membrane |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0045121 | Cellular component | membrane raft |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005757 | Cellular component | mitochondrial permeability transition pore complex |
GO_0045202 | Cellular component | synapse |
GO_0046930 | Cellular component | pore complex |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005634 | Cellular component | nucleus |
GO_0015288 | Molecular function | porin activity |
GO_0015485 | Molecular function | cholesterol binding |
GO_0097001 | Molecular function | ceramide binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008308 | Molecular function | voltage-gated monoatomic anion channel activity |
GO_0031210 | Molecular function | phosphatidylcholine binding |
GO_0008142 | Molecular function | oxysterol binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005515 | Molecular function | protein binding |
Gene name | VDAC1 |
Protein name | Voltage-dependent anion-selective channel protein 1 Alternative protein VDAC1 Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM) |
Synonyms | VDAC |
Description | FUNCTION: Forms a channel through the mitochondrial outer membrane and also the plasma membrane. The channel at the outer mitochondrial membrane allows diffusion of small hydrophilic molecules; in the plasma membrane it is involved in cell volume regulation and apoptosis. It adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mV. The open state has a weak anion selectivity whereas the closed state is cation-selective . Binds various signaling molecules, including the sphingolipid ceramide, the phospholipid phosphatidylcholine, and the sterols cholesterol and oxysterol . In depolarized mitochondria, acts downstream of PRKN and PINK1 to promote mitophagy or prevent apoptosis; polyubiquitination by PRKN promotes mitophagy, while monoubiquitination by PRKN decreases mitochondrial calcium influx which ultimately inhibits apoptosis . May participate in the formation of the permeability transition pore complex (PTPC) responsible for the release of mitochondrial products that triggers apoptosis . May mediate ATP export from cells . . |
Accessions | P21796 ENST00000425992.2 L8ECA2 ENST00000265333.8 ENST00000395044.7 ENST00000395047.6 C9JI87 |